Metoprolol vs. Ramipril
See how Metoprolol and Ramipril compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Metoprolol is a beta-blocker that also treats angina and heart failure, while ramipril is an ACE inhibitor mainly used for blood pressure and cardiovascular risk reduction.
Both come as once-daily oral options, but metoprolol needs a slow taper when stopping while ramipril usually does not.
Metoprolol's most common side effects involve heart rate and blood pressure changes, while ramipril's most common side effect is a persistent dry cough.
Metoprolol vs. Ramipril Drug Summary
Metoprolol
Metoprolol succinate is a beta-1 selective beta-blocker used to treat high blood pressure, angina, and stable heart failure. It comes as an extended-release tablet taken once a day, starting at a low dose and increasing over several weeks. It works by slowing the heart rate and reducing the force of each heartbeat.
Ramipril
Ramipril is an ACE inhibitor used to lower blood pressure, reduce cardiovascular risk in high-risk patients, and treat heart failure after a heart attack. It is taken as a capsule once or twice a day, starting at a low dose and increasing based on blood pressure response. It works by relaxing blood vessels by blocking the enzyme that produces angiotensin II.
Metoprolol vs. Ramipril Side Effects
Metoprolol
Ramipril
Metoprolol vs. Ramipril Dosage
Metoprolol
Ramipril
| STAGE | DOSE | WHEN |
| Starting dose | 12.5 mg once daily | Weeks 1-2 |
| Maximum dose | 100 mg once daily | Week 5 onward |
| Dose changes | 3 increases | Every 2 weeks |
| STAGE | DOSE | WHEN |
| Starting dose | 2.5 mg once daily | Week 1 |
| Maximum dose | Up to 20 mg once daily | If needed |
| Dose changes | 3 increases | Every week |
Metoprolol
| STAGE | DOSE | WHEN |
| Starting dose | 12.5 mg once daily | Weeks 1-2 |
| Maximum dose | 100 mg once daily | Week 5 onward |
| Dose changes | 3 increases | Every 2 weeks |
Ramipril
| STAGE | DOSE | WHEN |
| Starting dose | 2.5 mg once daily | Week 1 |
| Maximum dose | Up to 20 mg once daily | If needed |
| Dose changes | 3 increases | Every week |
Metoprolol vs. Ramipril Indications
Metoprolol
Metoprolol succinate is FDA-approved for hypertension, angina, and stable heart failure (NYHA Class II-IV). Doctors also prescribe it off-label for atrial fibrillation rate control, migraine prevention, and essential tremor.
Hypertension (to lower blood pressure)
Angina pectoris (chest pain)
Stable heart failure (NYHA Class II-IV)
Off-label: atrial fibrillation rate control
Ramipril
Ramipril is FDA-approved for hypertension, to reduce the risk of heart attack, stroke, or cardiovascular death in high-risk patients 55 and older, and for heart failure that develops after a heart attack. It is not approved to treat angina.
Hypertension (to lower blood pressure)
Cardiovascular risk reduction (age 55+, high risk)
Heart failure after a heart attack
Often combined with a thiazide diuretic
Metoprolol vs. Ramipril Pros and Cons
Metoprolol
Metoprolol has a broader FDA label, covering angina and heart failure in addition to hypertension, and decades of real-world use back its safety profile. It must be tapered gradually when stopping, and it carries beta-blocker-specific risks like bradycardia and masked hypoglycemia symptoms.
Pros
Also FDA-approved for angina and heart failure
Once-daily extended-release tablet
Decades of clinical use and established safety data
Available off-label for migraine and tremor control
Cons
Must be tapered slowly, never stopped abruptly
Contraindicated in bradycardia and certain heart blocks
Can cause fatigue and depression as class effects
May mask symptoms of low blood sugar in diabetics
Ramipril
Ramipril is one of the best-studied ACE inhibitors for cardiovascular risk reduction, including in patients without diagnosed hypertension. Its main drawbacks are a class-wide dry cough and pregnancy risks that require stopping the drug immediately if pregnancy occurs.
Pros
FDA-approved to cut cardiovascular risk even without hypertension
Can typically be stopped without a slow taper
Does not commonly cause bradycardia or mask low blood sugar
Well-studied in large outcome trials like HOPE and AIRE
Cons
Class-wide risk of persistent dry cough
Contraindicated in pregnancy; must stop immediately if pregnant
Risk of angioedema, especially with the first dose
Only approved for heart failure after a heart attack, not general heart failure
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.